Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR | Market Cap | 564.16B +37.9% |
| Revenue (ttm) | 168.27B +14.0% |
| Net Income | 6.04B -24.9% |
| EPS | 4.76 -29.1% |
| Shares Out | 1.62B |
| PE Ratio | 73.23 |
| Forward PE | 61.97 |
| Dividend | 0.50 (0.14%) |
| Ex-Dividend Date | Jul 4, 2025 |
| Volume | 2,064,223 |
| Average Volume | 4,362,496 |
| Open | 344.05 |
| Previous Close | 348.60 |
| Day's Range | 338.00 - 344.10 |
| 52-Week Range | 308.45 - 424.95 |
| Beta | 0.25 |
| RSI | 39.36 |
| Earnings Date | May 14, 2026 |
About Biocon
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, a... [Read more]
Financial Performance
In fiscal year 2025, Biocon's revenue was 152.62 billion, an increase of 3.43% compared to the previous year's 147.56 billion. Earnings were 10.13 billion, a decrease of -0.90%.
Financial StatementsNews
Biocon shares jump over 3% after US FDA nod for diabetes drug Dapagliflozin tablets
Biocon shares surged more than 3% in early morning trade on April 8, after the company announced a key regulatory approval from the US health regulator, boosting investor sentiment. The…
Biocon receives U.S. FDA approval for Dapagliflozin tablets
Biocon Pharma Limited, a subsidiary of Biocon Limited, has announced the receipt of approval from the U.S. Food and Drug Administration (FDA) for its Dapagliflozin Tablets, available in 5 mg…
Biocon launches Bosaya and Aukelso biosimilars in the U.S.
Biocon Limited, a global biopharmaceutical company, has announced the commercial launch of its denosumab biosimilars, Bosaya™ and Aukelso™, in the United States. These products, which are biosimilars ...
Pharma sector stocks fall sharply today: Sun Pharma down 4.89%, Aurobindo Pharma falls 4.48%, Biocon drops 4.67%
Indian pharmaceutical stocks declined in early trade on April 2, 2026, with most listed companies showing losses on both BSE and NSE. As of approximately 9:23-9:25 AM IST, the majority…
Biocon changes name of step-down subsidiary to Biocon Biologics Ireland
Biocon Limited has announced a change in the name of its step-down subsidiary. The entity previously known as Biosimilar Collaborations Ireland Limited, a subsidiary of Biocon Biologics Limited (BBL),...
Biocon announces changes in trustees for employee welfare trust
Biocon Limited has announced changes to the trustees of its Employees Welfare Trust, effective from 1 April 2026. The modifications were made in accordance with Article 13 of the Trust…
Biocon appoints Shreehas Tambe as CEO and Managing Director effective April 2026
Biocon Limited has announced the appointment of Shreehas Tambe as its Chief Executive Officer and Managing Director, effective 1 April 2026. This decision follows approvals from the Nomination & Remun...
St Patrick’s Day celebrated in Bengaluru with focus on India-Ireland ties
Bengaluru: Kiran Mazumdar-Shaw, honorary Consul General of Ireland and chairperson of Biocon, and Kevin Kelly, Ambassador of Ireland to India, hosted .
Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2%
Pharmaceutical stocks in India experienced a decline on March 19, 2026, during early trading hours. Market data as of approximately 9:46 AM IST (BSE) and 9:49 AM IST (NSE) showed…
Biocon receives U.S. FDA approval for Liraglutide injection
Biocon Pharma Limited, a wholly-owned subsidiary of Biocon, has secured approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Liraglutide I...
Stocks to watch today, February 25: Hindalco, Biocon, Power Grid, Lupin, IRFC and more
A host of corporate developments across metals, pharma, infrastructure, renewables and financial services are likely to keep several stocks in...
Pharma sector stocks today, Feb 20: Novartis India rally 20%, Biocon jumps 1.36%, Alembic rises 1.11%
The Indian pharmaceutical sector showed mixed performance on February 20, 2026, during early trading hours. The S&P BSE Healthcare Index...
Biocon Ltd (BOM:532523) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Biocon Ltd (BOM:532523) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions
Q3 2026 Biocon Ltd Earnings Call Transcript
Q3 2026 Biocon Ltd Earnings Call Transcript
Pharma sector stocsk today, Feb 12: Hikal jumps 13.46%, Zydus up 2.44%, Biocon rises 2.31%
The Indian pharma sector showed mixed performance on February 12, 2026, as of around 10:10 AM IST. The data reflects...
Biocon shares in focus as FM Sitharaman announces Rs 100 billion allocation for biopharma sector
Shares of Biocon are in focus on Sunday, February 1, after a major policy announcement for the biopharma industry in...
Pharma sector stocks down today: Divi’s Laboratories falls nearly 3%, Biocon drops 1.09%, Sun Pharma down 0.45%
The Indian pharmaceutical sector experienced downward pressure on January 12, 2026, amid broader market trends. The S&P BSE Healthcare index...
Top stocks to watch today, January 7: Titan Company, Mahindra, Godrej Consumer, Jubilant, Biocon and more
Indian equities are likely to open lower on Wednesday, mirroring mixed cues from global markets. Against this backdrop, several listed...
Biocon employee found dead on Bengaluru campus, police probe underway
A 26-year-old employee of biopharmaceutical company Biocon was found dead on the company’s Bengaluru campus on Tuesday, prompting a police...
Biocon staffer jumps to death from office building in Bengaluru
Bengaluru: A 26-year-old employee with Biocon allegedly jumped to his death from the fifth floor of the biopharmaceutical company building on Hosur Ro.
Biocon Employee, 26, Found Dead At Bengaluru Office
A 26-year-old employee of Biocon was found dead on the company premises at Bengaluru's Electronic City Phase-II on Tuesday.
Ajanta Pharma shares jump over 4% after signing in-licensing agreement with Biocon
Shares of Ajanta Pharma Ltd. moved over 4% higher in early trade after the company announced a strategic in-licensing agreement...
Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets
Biocon Limited has announced the signing of an out-licensing agreement with Ajanta Pharma Ltd for the marketing of its vertically...
Biocon Biologics secures full global rights for Hulio biosimilar Adalimumab
Biocon Biologics Limited, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that it has secured full...
Biocon shares rise jump 2% after US FDA issues VAI status for New Jersey facility
Biocon shares traded higher in early deals after the company announced that it has received an Establishment Inspection Report (EIR)...